Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for Treatment of Cartilage Defects
Public ClinicalTrials.gov record NCT03262909. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Open-Label, Multicenter Pivotal Study to Evaluate the Safety and Efficacy of GelrinC® for the Treatment of Symptomatic Articular Cartilage Defects of the Femoral Condyle: A Comparison to Historical Control Microfracture
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Multicenter, open-label, controlled, non-randomized, double arm trial with a prospective treatment arm (GelrinC). This study compares the efficacy and safety of GelrinC to a historical control arm (microfracture) in the treatment of cartilage defects in the knee.
Study identification
- NCT ID
- NCT03262909
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 181 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 14, 2017 (Actual)
- Primary completion
- Apr 2023 (Estimated)
- Completion
- Nov 2024 (Estimated)
- Last update posted
- Mar 22, 2022
2017 – 2024
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Horizon Clinical Research | La Mesa | California | 91942 | — |
| Hoag Orthopedics | Orange | California | 92868 | — |
| University of Colorado | Denver | Colorado | 80222 | — |
| Shrock Clinical Research | Fort Lauderdale | Florida | 33316 | — |
| Andrews Institute | Gulf Breeze | Florida | 32561 | — |
| Jewett Orthopaedic Clinic | Orlando | Florida | 32822 | — |
| Optim Orthopedics | Savannah | Georgia | 31405 | — |
| Midwest Orthopaedics at Rush | Chicago | Illinois | 60612 | — |
| Peninsula Orthopaedic Associates | Salisbury | Maryland | 21804 | — |
| Tria Institute | Bloomington | Minnesota | 55431 | — |
| Alpine Orthopedics | Bozeman | Montana | 59718 | — |
| University Orthopedics Center | Altoona | Pennsylvania | 16602 | — |
| Mansfield Orthopedics | Morrisville | Vermont | 05661 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03262909, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 22, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03262909 live on ClinicalTrials.gov.